Join Fund Library now and get free access to personalized features to help you manage your investments.

RBC Life Science and Technology Fund Series A

U.S. Equity

FundGrade A Click for more information on Fundata’s FundGrade

FundGrade A

Click for more information on Fundata’s FundGrade.

Fundata ESG GradeA Click for more information on Fundata’s ESG Grade

Fundata ESG Grade A

Click for more information on Fundata’s ESG Grade.

FundGrade A+® Rating Recipient

FundGrade A+® Rating Recipient

2023, 2022, 2021, 2020, 2015

Click for more information on Fundata’s FundGrade

NAVPS
(04-18-2024)
$44.69
Change
-$0.21 (-0.46%)

As at March 31, 2024

As at December 31, 2023

As at February 29, 2024

Period
Loading...

Legend

RBC Life Science and Technology Fund Series A

Compare Options


Fund Returns

Inception Return (July 31, 1995): 7.93%

Fund Returns
Row Heading Return Annualized Return
1 Mth 3 Mth 6 Mth YTD 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6 Yr 7 Yr 8 Yr 9 Yr 10 Yr
Fund 1.83% 14.98% 26.91% 14.98% 39.30% 16.84% 14.66% 19.96% 17.28% 17.16% 17.03% 17.47% 14.63% 16.51%
Benchmark 3.07% 13.26% 23.76% 13.26% 30.04% 14.00% 14.30% 19.94% 15.37% 15.05% 14.39% 15.08% 13.81% 15.28%
Category Average 2.94% 22.06% 22.06% 11.88% 26.39% 10.39% 10.21% 17.40% 12.02% 11.35% 11.08% 11.62% 10.10% 11.05%
Category Rank 1,091 / 1,374 276 / 1,361 259 / 1,343 276 / 1,361 182 / 1,288 43 / 1,216 85 / 1,158 225 / 1,095 39 / 993 37 / 887 53 / 812 36 / 706 45 / 652 27 / 573
Quartile Ranking 4 1 1 1 1 1 1 1 1 1 1 1 1 1

Monthly Return

Monthly Return
Return % Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Fund 1.82% 6.06% 2.54% 2.57% 1.76% -5.03% 0.86% 8.09% 1.25% 5.68% 6.85% 1.83%
Benchmark 1.90% 0.62% 3.76% 2.72% 1.05% -4.85% 0.44% 6.86% 1.80% 3.00% 6.70% 3.07%

Best Monthly Return Since Inception

37.88% (February 2000)

Worst Monthly Return Since Inception

-21.85% (February 2001)

Calendar Return (%)

Calendar Return
Return % 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fund 26.86% 21.81% -0.84% 22.08% 8.77% 25.94% 29.23% 24.97% -22.89% 37.42%
Benchmark 24.19% 20.77% 8.65% 13.80% 3.98% 25.18% 16.07% 28.16% -12.52% 23.32%
Category Average 16.59% 10.40% 6.16% 13.43% -2.19% 22.72% 13.97% 23.22% -14.41% 18.85%
Quartile Ranking 1 1 4 1 1 2 1 2 4 1
Category Rank 26/ 554 85/ 645 601/ 693 110/ 783 90/ 875 306/ 950 140/ 1,063 454/ 1,139 953/ 1,196 119/ 1,260

Best Calendar Return (Last 10 years)

37.42% (2023)

Worst Calendar Return (Last 10 years)

-22.89% (2022)

Asset Allocation

Asset Allocation
Name Percent
US Equity 94.16
International Equity 3.23
Cash and Equivalents 2.13
Canadian Equity 0.49
Other -0.01

Sector Allocation

Sector Allocation
Name Percent
Technology 65.76
Healthcare 21.91
Financial Services 3.42
Consumer Services 2.38
Cash and Cash Equivalent 2.13
Other 4.40

Geographic Allocation

Geographic Allocation
Name Percent
North America 96.78
Europe 2.68
Latin America 0.38
Asia 0.16

Top Holdings

Top Holdings
Name Percent
Microsoft Corp 11.09
Apple Inc 9.34
Alphabet Inc Cl A 8.01
NVIDIA Corp 5.92
Meta Platforms Inc Cl A 4.46
UnitedHealth Group Inc 2.75
Eli Lilly and Co 2.60
Broadcom Inc 2.46
Adobe Inc 1.77
Visa Inc Cl A 1.75

Equity Style

Market capitalization is large. Equity style is growth.

Fixed Income Style

Fixed income style data not available
Period: 

Risk vs Return (3 Yr)

RBC Life Science and Technology Fund Series A

Median

Other - U.S. Equity

3 Yr Annualized

Standard Deviation 16.77% 15.70% 15.20%
Beta 1.09% 1.01% 1.10%
Alpha -0.01% 0.02% 0.00%
Rsquared 0.87% 0.86% 0.84%
Sharpe 0.75% 0.98% 1.00%
Sortino 1.11% 1.49% 1.45%
Treynor 0.12% 0.15% 0.14%
Tax Efficiency 100.00% 100.00% 100.00%
Volatility Volatility rating is 9 on a scale of 1 to 10 Volatility rating is 7 on a scale of 1 to 10 Volatility rating is 9 on a scale of 1 to 10

Risk Rating

Rating 9 out of ten

Annualized Key Ratio Period Comparison

Key Ratio
Key Ratio 1 Yr 3 Yr 5 Yr 10 Yr
Standard Deviation 12.08% 16.77% 15.70% 15.20%
Beta 0.97% 1.09% 1.01% 1.10%
Alpha 0.08% -0.01% 0.02% 0.00%
Rsquared 0.72% 0.87% 0.86% 0.84%
Sharpe 2.44% 0.75% 0.98% 1.00%
Sortino - 1.11% 1.49% 1.45%
Treynor 0.31% 0.12% 0.15% 0.14%
Tax Efficiency 100.00% 100.00% 100.00% 100.00%

Fundata ESG Metrics

Fundata ESG Score

The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.

Fundata E Score

Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.

Fundata S Score

Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.

Fundata G Score

Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.

Powered by OWL Analytics. For more information, please contact Fundata Canada.

Fund Details

Start Date July 31, 1995
Instrument Type Mutual Fund
Share Class Commission Based Advice
Legal Status Trust
Sales Status Open
Currency CAD
Distribution Frequency Annual
Assets ($mil) $1,770

Fund Codes

FundServ Code Load Code Sales Status
RBF274

Investment Objectives

The objective of the fund is to provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Investment Strategy

The fund’s investment process is primarily based on fundamental research, although the portfolio manager will also consider quantitative and technical factors. Stock selection decisions are ultimately based on an understanding of the company, its business and its outlook. Life science investments include biotechnology, medical devices and services, pharmaceuticals and medical instruments.

Portfolio Manager(s)

Name Start Date
Rob Cavallo 01-01-2014
Marcello Montanari 02-22-2021

Management and Organization

Fund Manager RBC Global Asset Management Inc.
Advisor RBC Global Asset Management Inc.
Custodian RBC Investor Services Trust (Canada)
Registrar RBC Global Asset Management Inc.
Distributor Royal Mutual Funds Inc.
Auditor PriceWaterhouseCoopers LLP

Investment Minimums

RSP Eligible Yes
PAC Allowed Yes
PAC Initial Investment 25
PAC Subsequent 25
SWP Allowed Yes
SWP Min Balance 10,000
SWP Min Withdrawal 100

Fees

MER 2.05%
Management Fee 1.75%
Load No Load
FE Max -
DSC Max -
Trailer Fee Max (FE) -
Trailer Fee Max (DSC) -
Trailer Fee Max (NL) 1.00%
Trailer Fee Max (LL) -

Join Fund Library now and get free access to personalized features to help you manage your investments.